Salvat

Salvat is a mature, commercial-stage Spanish pharmaceutical company with nearly 70 years of history, specializing in small molecule drugs for Otolaryngology and Ophthalmology. It has achieved full vertical integration with in-house R&D, three manufacturing plants in Spain, and a production line in Florida, supporting a portfolio of established OTC and prescription brands like Cristalmina and Cetraxal. The company is privately held, employs nearly 500 people, and pursues steady growth through technological innovation, strategic alliances, and international expansion, particularly in the US market.

Focused on pharmaceutical technology development, including formulation science and specialized drug delivery systems for small molecules (e.g., Orally Dispersible Tablets, otic solutions). Aims to be a hub for pharmaceutical tech development.

Salvat competes in niche therapeutic areas (ENT, Ophthalmology) against both large multinational pharmaceutical companies and specialized players. Its competitive advantage is deep expertise in formulation technology, full vertical integration, and strong brand loyalty in its home market. In the US, it faces intense competition from larger firms with established sales forces and broader portfolios.